Lalji K Gediya Selected Research

Lalji K Gediya Research Topics

Disease

12	Prostatic Neoplasms (Prostate Cancer) 01/2018 - 12/2004
11	Neoplasms (Cancer) 01/2018 - 12/2004
4	Breast Neoplasms (Breast Cancer) 07/2014 - 12/2004
1	Neoplasm Metastasis (Metastasis) 03/2019
1	Triple Negative Breast Neoplasms 03/2019
1	Carcinogenesis 01/2013
1	Carcinoma (Carcinomatosis) 05/2012

Drug/Important Bio-Agent (IBA)

6	Androgen Receptors (Androgen Receptor)IBA 01/2018 - 05/2007
4	4-(1H-imidazol-1-yl)retinoic acidIBA 07/2014 - 12/2004
4	Tretinoin (Retinoic Acid)FDA LinkGeneric 05/2012 - 12/2004
3	Histone Deacetylase InhibitorsIBA 01/2013 - 03/2008
2	ChemokinesIBA 03/2019 - 01/2013
2	Eukaryotic Initiation Factor-4EIBA 03/2019 - 01/2018
2	Mitogen-Activated Protein KinasesIBA 03/2019 - 01/2018
2	Phosphotransferases (Kinase)IBA 03/2019 - 01/2018
2	Proteins (Proteins, Gene)FDA Link 01/2018 - 04/2008
2	3- hydroxy- 17- (1H- benzimidazole- 1- yl)androsta- 5,16- dieneIBA 10/2017 - 06/2013
2	Estrogen ReceptorsIBA 01/2013 - 05/2012
2	Vorinostat FDA Link 01/2013 - 07/2005
2	AndrogensIBA 11/2011 - 04/2005
2	Steroid 17-alpha-Hydroxylase (17 alpha Hydroxylase)IBA 08/2008 - 04/2005
2	Androgen Antagonists (Antiandrogens)IBA 08/2008 - 04/2005
2	Hormones (Hormone)IBA 07/2008 - 04/2008
2	RetinoidsIBA 03/2008 - 07/2005
1	4- (+;- )- (1H- imidazole- 1- yl)- N- (4- fluorophenyl)- (E)- retinamideIBA 03/2019
1	CytokinesIBA 03/2019
1	Mechanistic Target of Rapamycin Complex 1IBA 03/2019
1	Matrix Metalloproteinases (MMPs)IBA 01/2018
1	retinamideIBA 01/2018
1	Dihydrotachysterol (AT 10)IBA 01/2018
1	VimentinIBA 01/2018
1	Cadherins (E-Cadherin)IBA 01/2018
1	Prostate-Specific Antigen (Semenogelase)IBA 01/2018
1	Cyclin D1IBA 01/2018
1	Therapeutic UsesIBA 01/2018
1	CateninsIBA 01/2018
1	ClaudinsIBA 01/2018
1	LigandsIBA 10/2017
1	Aromatase InhibitorsIBA 07/2014
1	Aromatase (CYP19)IBA 07/2014
1	Letrozole (Femara)FDA LinkGeneric 07/2014
1	ThapsigarginIBA 07/2014
1	bardoxolone methylIBA 01/2013
1	Macrophage Colony-Stimulating FactorIBA 01/2013
1	bardoxoloneIBA 01/2013
1	TriterpenesIBA 01/2013
1	Drug CombinationsIBA 01/2013
1	A 7 (A-7)IBA 01/2013
1	Methylnitrosourea (N-Methyl-N-nitrosourea)IBA 05/2012
1	Estrogens (Estrogen)FDA Link 05/2012
1	Estradiol (Delestrogen)FDA LinkGeneric 05/2012
1	abirateroneIBA 11/2011
1	Abiraterone AcetateIBA 11/2011
1	Irinotecan (Camptosar)FDA LinkGeneric 11/2009
1	CamptothecinIBA 11/2009
1	Topotecan (Hycamtin)FDA LinkGeneric 11/2009
1	bicalutamide (Casodex)FDA LinkGeneric 08/2008
1	3beta- hydroxy- 17- (1H- benzimidazole- 1- yl)androsta- 5,16- dieneIBA 08/2008
1	Mixed Function Oxygenases (Monooxygenases)IBA 08/2008
1	ProdrugsIBA 07/2008
1	Isotretinoin (Accutane)FDA LinkGeneric 03/2008
1	tacedinaline (CI 994)IBA 03/2008
1	theasinensin AIBA 03/2008
1	entinostat (MS 275)IBA 03/2008
1	Histone Deacetylases (Histone Deacetylase)IBA 07/2005
1	E 10 (E-10)IBA 04/2005
1	Carboxylic AcidsIBA 12/2004
1	Growth InhibitorsIBA 12/2004
1	Retinoic Acid Receptors (Retinoic Acid Receptor)IBA 12/2004

Therapy/Procedure

4	Therapeutics 03/2019 - 11/2009
3	Castration 01/2018 - 04/2005
1	Chemoprevention 01/2013